Copyright Reports & Markets. All rights reserved.

Global Artificial Pancreas Devices Systems Market Growth 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Artificial Pancreas Devices Systems Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Artificial Pancreas Devices Systems Consumption 2014-2024
        • 2.1.2 Artificial Pancreas Devices Systems Consumption CAGR by Region
      • 2.2 Artificial Pancreas Devices Systems Segment by Type
        • 2.2.1 Threshold Suspended Device Systems
        • 2.2.2 Hybrid Closed-loop APDS
        • 2.2.3 Other Systems
      • 2.3 Artificial Pancreas Devices Systems Consumption by Type
        • 2.3.1 Global Artificial Pancreas Devices Systems Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Artificial Pancreas Devices Systems Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Artificial Pancreas Devices Systems Sale Price by Type (2014-2019)
      • 2.4 Artificial Pancreas Devices Systems Segment by Application
        • 2.4.1 Hospitals
        • 2.4.2 Clinics
      • 2.5 Artificial Pancreas Devices Systems Consumption by Application
        • 2.5.1 Global Artificial Pancreas Devices Systems Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Artificial Pancreas Devices Systems Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Artificial Pancreas Devices Systems Sale Price by Application (2014-2019)

      3 Global Artificial Pancreas Devices Systems by Players

      • 3.1 Global Artificial Pancreas Devices Systems Sales Market Share by Players
        • 3.1.1 Global Artificial Pancreas Devices Systems Sales by Players (2017-2019)
        • 3.1.2 Global Artificial Pancreas Devices Systems Sales Market Share by Players (2017-2019)
      • 3.2 Global Artificial Pancreas Devices Systems Revenue Market Share by Players
        • 3.2.1 Global Artificial Pancreas Devices Systems Revenue by Players (2017-2019)
        • 3.2.2 Global Artificial Pancreas Devices Systems Revenue Market Share by Players (2017-2019)
      • 3.3 Global Artificial Pancreas Devices Systems Sale Price by Players
      • 3.4 Global Artificial Pancreas Devices Systems Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Artificial Pancreas Devices Systems Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Artificial Pancreas Devices Systems Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Artificial Pancreas Devices Systems by Regions

      • 4.1 Artificial Pancreas Devices Systems by Regions
        • 4.1.1 Global Artificial Pancreas Devices Systems Consumption by Regions
        • 4.1.2 Global Artificial Pancreas Devices Systems Value by Regions
      • 4.2 Americas Artificial Pancreas Devices Systems Consumption Growth
      • 4.3 APAC Artificial Pancreas Devices Systems Consumption Growth
      • 4.4 Europe Artificial Pancreas Devices Systems Consumption Growth
      • 4.5 Middle East & Africa Artificial Pancreas Devices Systems Consumption Growth

      5 Americas

      • 5.1 Americas Artificial Pancreas Devices Systems Consumption by Countries
        • 5.1.1 Americas Artificial Pancreas Devices Systems Consumption by Countries (2014-2019)
        • 5.1.2 Americas Artificial Pancreas Devices Systems Value by Countries (2014-2019)
      • 5.2 Americas Artificial Pancreas Devices Systems Consumption by Type
      • 5.3 Americas Artificial Pancreas Devices Systems Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Artificial Pancreas Devices Systems Consumption by Countries
        • 6.1.1 APAC Artificial Pancreas Devices Systems Consumption by Countries (2014-2019)
        • 6.1.2 APAC Artificial Pancreas Devices Systems Value by Countries (2014-2019)
      • 6.2 APAC Artificial Pancreas Devices Systems Consumption by Type
      • 6.3 APAC Artificial Pancreas Devices Systems Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Artificial Pancreas Devices Systems by Countries
        • 7.1.1 Europe Artificial Pancreas Devices Systems Consumption by Countries (2014-2019)
        • 7.1.2 Europe Artificial Pancreas Devices Systems Value by Countries (2014-2019)
      • 7.2 Europe Artificial Pancreas Devices Systems Consumption by Type
      • 7.3 Europe Artificial Pancreas Devices Systems Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Artificial Pancreas Devices Systems by Countries
        • 8.1.1 Middle East & Africa Artificial Pancreas Devices Systems Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Artificial Pancreas Devices Systems Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Artificial Pancreas Devices Systems Consumption by Type
      • 8.3 Middle East & Africa Artificial Pancreas Devices Systems Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Artificial Pancreas Devices Systems Distributors
      • 10.3 Artificial Pancreas Devices Systems Customer

      11 Global Artificial Pancreas Devices Systems Market Forecast

      • 11.1 Global Artificial Pancreas Devices Systems Consumption Forecast (2019-2024)
      • 11.2 Global Artificial Pancreas Devices Systems Forecast by Regions
        • 11.2.1 Global Artificial Pancreas Devices Systems Forecast by Regions (2019-2024)
        • 11.2.2 Global Artificial Pancreas Devices Systems Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Artificial Pancreas Devices Systems Forecast by Type
      • 11.8 Global Artificial Pancreas Devices Systems Forecast by Application

      12 Key Players Analysis

      • 12.1 Medtronic
        • 12.1.1 Company Details
        • 12.1.2 Artificial Pancreas Devices Systems Product Offered
        • 12.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Medtronic News
      • 12.2 Bigfoot Biomedical
        • 12.2.1 Company Details
        • 12.2.2 Artificial Pancreas Devices Systems Product Offered
        • 12.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Bigfoot Biomedical News
      • 12.3 Beta Bionics
        • 12.3.1 Company Details
        • 12.3.2 Artificial Pancreas Devices Systems Product Offered
        • 12.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Beta Bionics News
      • 12.4 Admetsys
        • 12.4.1 Company Details
        • 12.4.2 Artificial Pancreas Devices Systems Product Offered
        • 12.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Admetsys News
      • 12.5 Insulet
        • 12.5.1 Company Details
        • 12.5.2 Artificial Pancreas Devices Systems Product Offered
        • 12.5.3 Insulet Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Insulet News
      • 12.6 Tandem Diabetes Care
        • 12.6.1 Company Details
        • 12.6.2 Artificial Pancreas Devices Systems Product Offered
        • 12.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Tandem Diabetes Care News
      • 12.7 Defymed
        • 12.7.1 Company Details
        • 12.7.2 Artificial Pancreas Devices Systems Product Offered
        • 12.7.3 Defymed Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Defymed News

      ...

        13 Research Findings and Conclusion

        The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.

        Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.

        A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."

        An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
        The classification of artificial pancreas devices systems includes threshold suspended device systems and hybrid closed-loop APDS, and the proportion of artificial pancreas devices systems in 2017 is about 60%, and the proportion is in decreasing trend from 2013 to 2017.
        Artificial pancreas devices systems are widely used in hospital and clinic. The most proportion of artificial pancreas devices systems is in hospital, and the proportion in 2017 is about 59%.
        North America is the largest consumption place, with a consumption market share nearly 54% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 35%.

        According to this study, over the next five years the Artificial Pancreas Devices Systems market will register a 13.8% CAGR in terms of revenue, the global market size will reach US$ 120 million by 2024, from US$ 56 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Artificial Pancreas Devices Systems business, shared in Chapter 3.

        This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Pancreas Devices Systems market by product type, application, key manufacturers and key regions and countries.

        This study considers the Artificial Pancreas Devices Systems value and volume generated from the sales of the following segments:

        Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
        Threshold Suspended Device Systems
        Hybrid Closed-loop APDS
        Other Systems
        Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
        Hospitals
        Clinics

        This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
        Americas
        United States
        Canada
        Mexico
        Brazil
        APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
        Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

        The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
        Medtronic
        Bigfoot Biomedical
        Beta Bionics
        Admetsys
        Insulet
        Tandem Diabetes Care
        Defymed
        ...

        In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

        Research objectives
        To study and analyze the global Artificial Pancreas Devices Systems consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
        To understand the structure of Artificial Pancreas Devices Systems market by identifying its various subsegments.
        Focuses on the key global Artificial Pancreas Devices Systems manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
        To analyze the Artificial Pancreas Devices Systems with respect to individual growth trends, future prospects, and their contribution to the total market.
        To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
        To project the consumption of Artificial Pancreas Devices Systems submarkets, with respect to key regions (along with their respective key countries).
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
        To strategically profile the key players and comprehensively analyze their growth strategies.

        Buy now